CJC 1295 with DAC is a modified synthetic peptide engineered to stimulate growth hormone-releasing hormone receptors through prolonged biological activity and sustained peptide signaling pathways. The addition of Drug Affinity Complex (DAC) technology significantly extends the peptide’s half-life, making it widely researched in experimental models involving long-duration endocrine modulation and growth hormone secretion dynamics. Researchers investigate CJC 1295 with DAC for its role in peptide-mediated recovery pathways, metabolic activity, cellular repair signaling, and protein synthesis-related biological functions. Its long-acting structure is commonly explored in laboratory environments focused on hormonal rhythm regulation, tissue-support mechanisms, and extended receptor activation studies associated with growth hormone research. Due to its stability and prolonged activity profile, CJC 1295 with DAC remains a prominent compound in peptide-based scientific investigations involving endocrine communication and sustained biological signaling pathways. Each vial is supplied as research-grade lyophilized material with verified purity standards and controlled laboratory handling protocols.
Molecular Formula: C₁₆₅H₂₆₉N₄₇O₄₆
Molecular Weight: 3647.27 g/mol
Storage: Store lyophilized at −20°C under sterile laboratory conditions
FOR RESEARCH USE ONLY